Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print February 11, 2008
DOI: 10.2337/dc07-2185

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-2185v1
31/5/1021    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hohberg, C.
Right arrow Articles by Pfützner, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohberg, C.
Right arrow Articles by Pfützner, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State

Clothilde Hohberg, MD1, Thomas Forst, MD1,,2, Martin Larbig, PhD3, Michael Safinowski, PhD1, Stefan Diessel, MD1, Silvia Hehenwarter1, Matthias M. Weber, MD2, Thomas Schöndorf, PhD1 and Andreas Pfützner, MD, PhD1

1Institute for Clinical Research and Development, Mainz, Germany
2Johannes Gutenberg University, Dept. Endocrinology, Mainz, Germany
3sanofi-aventis, Berlin, Germany

thomasf{at}ikfe.de

ABSTRACT

OBJECTIVE: To investigate the effect of insulin glulisine on postprandial microvascular blood flow in T2DM.

RESEARCH DESIGN AND METHODS: Fifteen patients with T2DM received insulin glulisine or human insulin before a liquid meal test. Thereafter, skin microvascular blood flow was measured by the use of laser Doppler fluxmetry (LDF), and blood samples were taken for the meaurement of plasma levels of glucose, insulin, intact proinsulin, ADMA, nitrotyrosine, IL-18, MMP-9, oxLDL, and FFA.

RESULTS: Insulin glulisine resulted in higher postpradial insulin levels (mean±SEM; AUC0–120:51.0±6.8 vs. 38.2±5.4 mU/L; p=0.004), while plasma glucose (AUC0–240: 158±9 vs. 180±9 mg/dl; p<0.05) and intact proinsulin (AUC0–240: 26.2±3.5 vs 31.2±4.3 pmol/L; p=0.002) were lower. Microvascular blood flow increased after insulin glulisine (27.9±3.1 to 51.7±9.9 AU; p<0.05), while only a minor increase was found during human insulin (27.9±3.1 to 34.4±7.8; n.s.). ADMA and Nitrotyrosine levels were reduced after insulin glulisine (p<0.05, respectively).

CONCLUSIONS: Insulin glulisine is superior to human insulin in restoring postprandial metabolic and microvascular physiology.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Clark
Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E732 - E750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.